
News & updates
1.
NAI selected Senior member. Prof. Vered Padler-Karavani was selected as a Senior Member of the National Academy of Inventors (NAI) as a member of the 2026 Class of Senior Members. This prestigious designation is a reflection of outstanding achievements in invention and innovation, and a testament of the commitment to advancing technology for the betterment of society. The NAI Senior Member program was designed to honor active researchers who have produced innovations with real-world impact. In 2026, there are only 945 NAI Senior Members across the globe, each recognized for their significant contributions to the welfare of society through their groundbreaking work, dedication to excellence in research, patents, licensing, and commercialization
2.
3.
4.
5.
6.
Funding opportunities through Horizon Europe, represented by research in our lab
Pausa Lecture of Tel-Aviv University, Vered Padler-Karavani, "Could Sugar Help Us Beat Cancer?
TAU Annual Report
7.
The article The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration was published in several news magazines: EurekAlert, Jerusalem Post, JPOST, ScienMag, Jewish Press, Cardiovascular business , News Medical, Odisha expo, Bioengineer, Medicalxpress, My asian marketplace , The jewish link , ISRAEL 365 NEWS, Dominiouruguay, News Breezer, Family news , News Founded.
8.
World Cancer Day, Vered Padler-Karavani's Lab, Shmunis School of Biomedicine & Cancer Research

9.
Sweet Science: Sneak peek to the lab of Dr. Vered Padler-Karavani

10.
The article Association between Neu5Gc carbohydrate and serum antibodies against it provides the molecular link to cancer: French NutriNet-Santé study, was published in several news magazines: Walla News, Jewish Press, Israel365news, Jerusalem Post, israel21c, medical-press, News-Medical and TV interview at Kan 11 news.
11.
The article Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer was highlighted in a new entry on "Therapeutic Antibodies Targeting Glycosylation" in Encyclopedia: Entry ID: 3331, Category: Pharmacology & Toxicology, Title: Therapeutic Antibodies Targeting Glycosylation Authors: Vered Padler-Karavani.
Dr. Vered Padler Karavani was invited by the ERC president Jean-Pierre Bourguignon to participate in the press-conference and interview “Tackling Cancer from Within – New Perspectives” at the World Economic Forum’s Annual meeting of the New Champions; Leadership 4.0- Succeeding in a New Era of Globalization”
The World Economic Forum engages leaders who have the vision and values to shape the future in this new context. To this end, the Annual Meeting of the New Champions is designed as the foremost global summit on innovation and entrepreneurship and gathers the foremost political, business and other leaders of society.
12.











